达维塔保健（DVA）今日夜盘股价大幅上涨14.52%，引起了市场的广泛关注。
消息面上，公司公布了2026年度财务指引，预计调整后每股收益在13.60美元至15.00美元之间，高于分析师预期的12.65美元。同时，公司发布的第四季度财报显示，调整后每股收益为3.40美元，营收为36.2亿美元，均超出市场预期。稳定的透析服务需求、较高的报销率以及运营状况的改善，共同推动了业绩向好。
此外，公司宣布将与临终关怀服务提供商Elara合作，开发针对肾脏的家庭护理模式，旨在改善患者治疗效果，这进一步增强了市场对公司未来增长潜力的信心。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.